Medicine and Dentistry
Beta Adrenergic Receptor Blocking Agent
100%
Combination Therapy
100%
Calcium Channel Blocking Agent
100%
Stable Angina Pectoris
100%
Stable Angina
100%
Blood Pressure
50%
Heart Rate
50%
Nifedipine
33%
Verapamil
33%
Patient
33%
Diseases
16%
Heart Left Ventricle Failure
16%
Patient Selection
16%
Exercise
16%
Drug Therapy
16%
Heart Performance
16%
Heart Left Ventricle Function
16%
Atrioventricular Node
16%
Chemotherapeutic Agent
16%
Symptom
16%
Heart Muscle Oxygen Consumption
16%
Drug
16%
Drug Interaction
16%
Heart Ventricle Conduction
16%
Diltiazem
16%
Monitoring
16%
Inpatient
16%
Clinical Trial
16%
Heart
16%
Rest
16%
Clinician
16%
Amaurosis
16%
INIS
therapy
100%
calcium
100%
patients
66%
additives
66%
drugs
50%
blood pressure
50%
monitoring
16%
clinical trials
16%
interactions
16%
diseases
16%
comparative evaluations
16%
performance
16%
management
16%
demand
16%
administration
16%
refractories
16%
symptoms
16%
doses
16%
exercise
16%
oxygen
16%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Beta Adrenergic Receptor Blocking Agent
100%
Stable Angina Pectoris
100%
Nifedipine
33%
Verapamil
33%
Diseases
16%
Oxygen
16%
Heart Left Ventricle Failure
16%
Drug Interaction
16%
Diltiazem
16%
Drug
16%
Symptom
16%
Blindness
16%
Pharmaceutical Therapy
16%
Biochemistry, Genetics and Molecular Biology
Beta Blocker
100%
Blood Pressure
50%
Heart Rate
50%
Nifedipine
33%
Verapamil
33%
Pressure
33%
Drug Interaction
16%
Heart Left Ventricle Function
16%
Exercise
16%
Heart Ventricle Conduction
16%
Heart Performance
16%
Diltiazem
16%
Heart Muscle Oxygen Consumption
16%
Dose
16%
Rest
16%